HIV Vaccine: Johnson & Johnson Ends Trial After Vaccine Fails to Stop Transmission

A Phase 1 study of a new experimental HIV vaccine is showing promising results among a small group of volunteers. The findings are showing that when a two-dose regimen of the vaccine is administered eight weeks apart, an immune response is triggered...
 
HIV Vaccine: Johnson & Johnson Ends Trial After Vaccine Fails to Stop Transmission
Read on  →
Here's How Much Protein You Need to Build Muscle
 
Read on  →
71% of LGBTQ Youth Say Their Mental Health Is Declining Due to Restrictive State Laws
 
Read on  →
Inflammatory Bowel Disease: How Oxygen Chambers, Apple Watches May Improve Treatment for Crohn's, Ulcerative Colitis
 
Read on  →
Colorectal Cancer: New Blood Test May Help Determine if Chemotherapy is Needed After Surgery
 
Read on  →
More top Reads
GET STARTED  →
 
Start a custom weight loss program
fb   tt   insta
View in browser

Did a friend send you this email? Subscribe here.
To see all newsletters, click here.

Privacy   |   Unsubscribe

© 2023 Healthline Media LLC
275 7th Ave., 24th Floor
New York, NY 10001

No comments:

Post a Comment